Table 1.
The values of the key metabolites in the study groups
| Metabolite | MW* | Multiplicity lethal/non-lethal |
|---|---|---|
| Ceramide (d18:1/22:0) | 4 | 0.503 |
| Ceramide (d18:1/24:0) | 9 | 0.531 |
| Ceramide (d18:1/24:0 OH) | 11 | 0.579 |
| Ceramide (d18:1/22:2 OH) | 12 | 0.564 |
| Ceramide (d18:1/23:0) or ceramide (d18:1/22:1 OH) | 12 | 0.529 |
| Ceramide (d18:1/25:0) | 13 | 0.524 |
| Glycosphingolipid (18:1/22:0) | 13 | 0.486 |
| Glycosphingolipid (18:1/24:1) | 15 | 0.356 |
| Ceramide (d18:1/20:1 OH) | 18 | 0.621 |
| Ceramide (d18:1/22:0 OH) | 18 | 0.685 |
| Ceramide (d18:1/24:1) | 19 | 0.450 |
| Ceramide (d18:1/20:0) | 21 | 0.658 |
| Ceramide (d18:1/18:0) | 23 | 0.695 |
| Ceramide (d18:1/26:1) | 23 | 0.702 |
| Sphingomyelin (d18:1/22:0 OH) | 23 | 0.663 |
| Ceramide (d18:1/16:0 OH) | 24 | 0.712 |
| Ceramide (d18:1/26:2) | 24 | 0.653 |
| Ceramide (d18:1/16:1 OH) | 25 | 0.731 |
| Ceramide (d18:1/24:2 OH) | 27 | 0.641 |
| Sphingomyelin (d18:1/22:2) | 27 | 0.683 |
| 3-Phosphoglyceric acid | 28 | 0.456 |
| Ceramide (d18:1/18:0 OH) | 28 | 0.680 |
| Sphingomyelin (d18:1/24:0) | 28 | 0.569 |
| Ceramide (d18:1/18:1 OH) | 29 | 0.719 |
| Ceramide (d18:1/18:1) | 29 | 0.738 |
| Corticosterone | 29 | 0.594 |
| Glycosphingolipid (18:1/20:0) | 29 | 0.648 |
| Sphingomyelin (d18:1/16:2 OH) | 29 | 0.750 |
| Sphingomyelin (d18:1/18:2 OH) | 30 | 0.686 |
| Plasmalogen (p18:0/22:6) | 31 | 0.655 |
| 5-Hydroxyindoleacetic acid | 32 | 1.788 |
| Glycosphingolipid (18:1/16:0) | 32 | 0.561 |
*MW – Mann–Whitney U-statistic value.